What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
about
The time-course of protection of the RTS,S vaccine against malaria infections and clinical diseaseThe March Toward Malaria VaccinesDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenHeterogeneity, mixing, and the spatial scales of mosquito-borne pathogen transmissionEnsemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccineA novel approach for measuring the burden of uncomplicated Plasmodium falciparum malaria: application to data from ZambiaThe public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models.A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coliEnhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya.A research agenda for malaria eradication: vaccines.Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity.Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmissionThe role of mathematical modelling in guiding the science and economics of malaria eliminationP. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.Modeling the public health impact of malaria vaccines for developers and policymakersImportance of factors determining the effective lifetime of a mass, long-lasting, insecticidal net distribution: a sensitivity analysisAge-shifting in malaria incidence as a result of induced immunological deficit: a simulation study.A periodically-forced mathematical model for the seasonal dynamics of malaria in mosquitoes.Tailoring a Combination Preerythrocytic Malaria VaccineOperational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.Malaria vaccines: looking back and lessons learnt.A mathematical model of the impact of present and future malaria vaccinesMathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings.The march toward malaria vaccines.Malaria Modeling in the Era of Eradication.Simulation of the cost-effectiveness of malaria vaccines.Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials.Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences?Simulating the impact of malaria vaccination: what has been learnt?Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral VectorsAgent-based models of malaria transmission: a systematic reviewThe Role of Mathematical Models in Vaccine Development and Public Health Decision Making
P2860
Q27304630-38EF9A27-3377-4D55-B04F-29EE43F61875Q28084325-A6EE7699-C4D9-4857-AA1F-6CF37CA1A024Q28477679-5DC056F5-C6F6-4278-BD33-71EA3F4F1B8EQ28536895-5A37D2AA-CD49-4848-A795-45A862480FF9Q28732752-AFC08DE1-6406-4CD2-A7F5-1FBD250EAC51Q30000809-6AAFDA64-C346-41F4-AC02-A06C2732F9D1Q30983587-E3BC21EA-4905-4F55-97FE-2388BF2A6313Q33485233-332A27C2-4706-4E72-ACF8-B2E59E389AFCQ33577093-94BDF198-F7EC-4FA7-9485-F371F2BD7226Q33587443-91C1206F-325F-443D-892E-D40C99C456D8Q33631268-8052ED8A-11E3-4034-9034-A4D3307BACF8Q33818046-37982DFB-F1AF-4227-8A18-1058B8BDAD76Q33926064-2F620DE2-9D96-41D6-A1F5-22150E97A5EDQ34193236-7575EF16-1607-440D-9323-6803C4D2B4F2Q34415327-520A937A-B7EC-4053-A675-525700FE3DB2Q34427744-57CB41B9-7B10-4C86-AEDD-7BDD4B4FD6A8Q34787802-AA243094-68AC-469F-90D1-2E1E7C4ED07BQ35739735-63E1BB83-DFF8-47A7-9141-3CF2EDA1085AQ35885315-250C6AA0-98E7-4ABF-97E8-487F87C99912Q35921267-2479C031-FC9F-4F02-A6AC-D57A3E119A43Q36631331-B9CE1C3F-06C7-4479-8730-19E4DFC13594Q36667896-1DFC7456-40AF-4611-B9D4-0C0851B4AEEEQ36719296-D23CE8DF-804C-4AC6-9F6A-4912ABDB99DDQ36858852-35676BB6-96F8-4B8B-B1AB-646EE38658E8Q37119364-23D480FD-4481-460A-A4A6-F67C825B0870Q38577638-D9C2ED56-4950-43CC-8DEE-1E4405A1E650Q39047637-07A6795B-7CE6-4A00-9111-08ED2C5F884FQ39515386-1F8F8974-A07D-41CC-9D2E-BFBAF7557F36Q39954682-6FFDA4A1-B44F-41BE-B5C5-125AD26C1756Q42710505-510AB782-E392-49EA-AA41-B02F6AF1E5D2Q48018173-A0145585-4C88-413B-B533-ADBB13A385F5Q56341814-4E0ABD81-F0FD-4EE5-88AD-6B33B54FEBA8Q56342178-9BB3B4A3-E1B0-4562-BB30-2F505646F629Q57097843-3ABCDA8C-32DF-4743-9C2B-8B231B11D1B6
P2860
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@ast
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@en
type
label
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@ast
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@en
prefLabel
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@ast
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@en
P2093
P2860
P1433
P1476
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines
@en
P2093
Alain Studer
Allan Schapira
Nicolas Maire
P2860
P356
10.1371/JOURNAL.PONE.0003193
P407
P577
2008-09-11T00:00:00Z